Prosulfocarb at center stage!

International audienceProsulfocarb is a thiocarbamate herbicide that is rapidly growing in use due to the progressive bioresistance of weeds to certain pesticides and the ban and/or limitation of others. However, the use of prosulfocarb is only recent, and the relevant literature is scarce. The environmental and food impact of prosulfocarb has already been observed, and its transfer mode from targeted crops to untargeted parcels has been investigated. This expertise highlights the volatilization effect to explain the pollution of lone parcels and hedge inefficiency against residue spreads

Prosulfocarb at center stage!

International audienceProsulfocarb is a thiocarbamate herbicide that is rapidly growing in use due to the progressive bioresistance of weeds to certain pesticides and the ban and/or limitation of others. However, the use of prosulfocarb is only recent, and the relevant literature is scarce. The environmental and food impact of prosulfocarb has already been observed, and its transfer mode from targeted crops to untargeted parcels has been investigated. This expertise highlights the volatilization effect to explain the pollution of lone parcels and hedge inefficiency against residue spreads

Viral respiratory tract infections in young children with cystic fibrosis: a prospective full-year seasonal study

Viral respiratory tract infections are common during early childhood. How they impact cystic fibrosis lung disease history in young children is poorly known. The principal aim of our study was to determinate respiratory tract infections frequency in this cystic fibrosis young population. Secondary outcomes were nature of viral agents recovered and impact of such infections

Pleuropneumonectomy as salvage therapy in children suffering from primary or metastatic sarcomas with pleural localizations

Pediatric sarcoma patients with pleuropulmonary lesions have a dismal prognosis because the impossibility to obtain local control. The aim of this study was to determine if pleuropneumonec-tomy (PP) could be a therapeutic option. We retrospectively reviewed nine patients who underwent salvage PP for pleuropulmonary localization of primary localized sarcoma or metastatic recurrence. Surgery and complications were analyzed, pulmonary function tests were conducted, and quality of life was determined with EORTC-QLQ-C30 questionnaire. At the time of PP age was between 9–17 years. Underlying disease included metastatic osteosarcoma (n = 5), Ewing sarcoma (two metastatic, one primary), and one primary undifferentiated sarcoma. Early complications occurred in three patients. Mean postoperative hospitalization stay was 14.5 days. Pulmonary function test showed 19–66% reduction of total lung capacity which led to mild exercise intolerance but did not affect daily life. Four patients died of multi-metastatic relapse <14 months after PP, one patient had a local recurrence, and four patients are in complete remission between 1.5 and 12 years after PP. In conclusion, in this small patient group treated with a pleuropneumonectomy for primary or metastatic lesions, outcome is variable; however, this extended surgical technique was generally quite well tolerated. Postoperative lung function seems well preserved, and it seems to lead to at least an extension of life with good quality and therefor can be considered as salvage therapy